1. Wang, Mengying, Chen, Binghong, Zhang, Wenrui, Lin, Yingying, Yang, Shaofeng. 2022. Dematin inhibits glioblastoma malignancy through RhoA-mediated CDKs downregulation and cytoskeleton remodeling. In Experimental cell research, 417, 113196. doi:10.1016/j.yexcr.2022.113196. https://pubmed.ncbi.nlm.nih.gov/35561787/
2. Ye, Ya-Ping, Jiao, Hong-Li, Wang, Shu-Yang, Liao, Wen-Ting, Ding, Yan-Qing. 2018. Hypermethylation of DMTN promotes the metastasis of colorectal cancer cells by regulating the actin cytoskeleton through Rac1 signaling activation. In Journal of experimental & clinical cancer research : CR, 37, 299. doi:10.1186/s13046-018-0958-1. https://pubmed.ncbi.nlm.nih.gov/30514346/
3. Hopkins, Paul C R. 2013. Neurodegeneration in a Drosophila model for the function of TMCC2, an amyloid protein precursor-interacting and apolipoprotein E-binding protein. In PloS one, 8, e55810. doi:10.1371/journal.pone.0055810. https://pubmed.ncbi.nlm.nih.gov/23409049/
4. Lu, Yunzhe, Hanada, Toshihiko, Fujiwara, Yuko, Han, Jongyoon, Chishti, Athar H. 2016. Gene disruption of dematin causes precipitous loss of erythrocyte membrane stability and severe hemolytic anemia. In Blood, 128, 93-103. doi:10.1182/blood-2016-01-692251. https://pubmed.ncbi.nlm.nih.gov/27073223/